查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2034928

全球週邊置入中心靜脈導管市場：市場規模、佔有率和趨勢分析（2026-2032 年）

Peripherally Inserted Central Catheter Market Size, Share, & Trends Analysis | Global | 2026-2032 | Includes: Single, Double, and 1 Other Catheter
出版日期: | 出版商: iData Research Inc. | 英文 127 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球週邊置入中心靜脈導管市場報告（至2032年）

2025年全球經週邊置入中心靜脈導管（PICC）市場規模約8.38億美元。預計該市場將以3.3%的複合年成長率成長，到2032年達到11億美元。

本報告涵蓋了週邊置入中心靜脈導管（PICC）的全球市場，包括單腔、雙腔和三腔裝置。

分析內容包括銷售量、平均售價 (ASP)、治療次數、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。

市場成長主要得益於新型PICC技術的出現、PICC作為CVC和PIVC替代方案的日益普及，以及高壓輸注相容型、帶瓣膜型、抗菌型和抗血栓型PICC裝置的持續應用。然而，感染風險和熟練護理人員短缺仍然是阻礙PICC進一步推廣應用的主要因素。

市場概覽

全球 PICC 市場包括週邊置入中心靜脈導管 ( PICC)，該導管用於透過周邊靜脈提供中長期血管通路，導管尖端位於中心靜脈內。

PICC導管廣泛應用於醫院、門診、腫瘤科、輸液治療和慢性病照護機構。當患者需要靜脈通路超過一周，或需要中心靜脈通路但無法置入傳統中心靜脈導管（CVC）時，通常會選擇PICC導管。

市場細分按管腔類型、裝置類型、套件類型和閥門類型進行。這包括單腔、雙腔和三腔裝置；兼容高壓注射和不相容高壓注射的PICC；導管尖端放置套件和傳統套件；以及帶閥門和不帶閥門的PICC。

產品差異化和漸進式創新持續塑造競爭格​​局。製造商正在拓展產品線，涵蓋帶有瓣膜、高壓輸注、多腔、抗菌和抗血栓等多種配置。這些設計旨在提升臨床療效、減少併發症、拓展應用場景，並支援最新的血管通路方案。

市場促進因素

新技術

新技術是PICC市場的主要驅動力。製造商正利用產品差異化來支撐高價策略，並在競爭激烈的血管通路領域中維持平均售價（ASP）。

市面上已有瓣PICC導管、高壓輸液PICC導管、三腔PICC導管、抗菌PICC導管和抗血栓PICC導管。這些產品有助於滿足臨床需求，例如預防感染、減少血栓形成、與影像診斷相容以及聯合治療。

採用新技術的產品通常比標準PICC定價更高。即使銷量成長緩慢，這也有助於防止整體平均售價（ASP）下降，並支持市場價值的成長。

持續改進現有PICC導管設計可望促進其應用。設計改善可降低感染和併發症發生率，提高置入便利性，並提升病患舒適度。

PICC 的使用範圍擴大

PICC使用量的增加是另一個重要的促進因素。 PICC數量增加主要體現在先前已植入CVC或PIVC的情況下，PICC的使用。

住院期間，大多數患者都會置入某種形式的靜脈導管。與中心靜脈導管（CVC）和周邊靜脈導管（PIVC）相比，經周邊靜脈置入的中心靜脈導管（PICC）的數量仍然較少，這為在鄰近的血管通路領域拓展應用留下了空間。

對於可能需要靜脈輸液超過一週的患者，PICC導管擴大在治療初期置入。雖然PICC導管比PIVC導管更昂貴，但它無需每72小時更換一次，從而節省時間並減輕整體護理負擔。

此外，由於感染率低，PICC導管在某些慢性血管通路病例中正逐漸取代CVC導管。隨著三腔PICC導管和抗菌技術的廣泛應用，預計PICC導管將繼續從CVC導管市場中搶佔部分佔有率。

護理師主導的職位安排和工作流程最佳化

PICC導管的實用優勢之一是通常可以由受過訓練的護理人員在床邊進行置入。這減少了醫生介入的需要，並降低了手術費用。

床旁置管也有助於簡化工作流程。這可以減少延誤，在某些情況下，還能避免使用手術室或介入室，使醫院能夠更靈活地管理血管通路需求。

隨著越來越多的醫院建立血管通路團隊和護理師主導的置管項目，PICC的使用率可能會進一步提高。在目前需要優先減輕醫生工作量、縮短置管時間和降低手術成本的環境下，這一點尤其重要。

市場限制

感染率

感染風險仍是PICC置入術的一大限制因素。導管相關感染是所有類型導管都面臨的主要問題，這將對醫院的臨床和經濟造成重大影響。

導管相關感染疾病平均會對醫院造成超過 25,000 美元的損失。雖然 PICC 的感染率通常低於 CVC，但當可以使用風險較低的 PIVC 替代時，PICC 的使用頻率仍有爭議。

這種擔憂可能會限制PICC在僅需短期通路或可使用較簡單的周邊導管治療的患者中的應用。雖然抗菌和抗血栓PICC的日益普及可能會減輕這種限制的影響，但感染風險仍將是選擇導管時的重要因素。

護理人員短缺

護理人員短缺可能是PICC置管的限制因素。 PICC置管的優點之一是可由受過訓練的護理師在床邊置入，但此優點取決於是否有足夠數量的合格專業。

當護理師人數不足時，可能沒有足夠的人手有效率地進行PICC置管。在這種情況下，可以改用其他靜脈通路裝置，例如置管更簡單快速的PIVC。

對於人員短缺或血管通路團隊能力有限的醫療機構而言，這種限制尤其突出。如果沒有訓練有素的人員，PICC導管的應用可能無法滿足臨床需求。

與PIVC和CVC的競爭

PICC導管與PIVC導管及CVC導管均有競爭關係。雖然PICC導管可以取代某些應用場景，但PIVC導管和CVC導管仍適用於特定的應用場景。

周邊靜脈置管（PIVC）操作簡單、快速且成本低廉，因此適用於許多短期靜脈通路需求。另一方面，中心靜脈置管（CVC）在需要高流速或緊急中心靜脈通路的重症監護病例中仍然至關重要。

由於每種導管的作用各不相同，PICC導管無法完全取代任何其他類型的導管。這限制了其潛在市場規模，PICC導管的成長將取決於患者的選擇是否恰當。

市場覆蓋範圍和數據範圍

  • 量化範圍：市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售單位數量、平均售價。
  • 定性範圍：市場促進因素和阻礙因素、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。
  • 目標時期：基準年為 2025 年，預測至 2032 年，歷史資料截至 2022 年。
  • 建立市場模型：根據治療量、競爭市場佔有率分析和預測假設，使用銷售量和平均售價 (ASP) 分析收入。
  • 目標設備：本報告涵蓋按管腔類型、設備類型、套件類型和閥門類型分類的週邊置入中心靜脈導管，包括具有抗菌或抗血栓特性的先進材料設備。

目標市場及區隔

週邊置入中心靜脈導管市場

  • 流明類型：單流明、雙流明、三流明。

當只需要一個通路時，可使用單腔PICC導管。雙腔和三腔PICC導管則用於更複雜的治療需求，例如需要管理多種藥物、液體或路徑的情況。

  • 設備類型：高壓注射相容型和非高壓注射相容型。

高壓輸液型PICC導管專為承受造影增強影像工作流程中較高的壓力而設計。非高壓輸液型PICC導管仍可用於常規輸液和血管通路需求。

根據材質類型，高壓注射相容型PICC導管可進一步分為先進材料導管和傳統導管。先進材料導管可能具有抗菌和抗血栓等特性，而傳統導管則不具備這些功能。

  • 套件類型：尖端安裝套件和傳統套件。

晶片植入套件包含與晶片植入系統配套使用的一次性產品。傳統套件包含標準植入組件，但不包含這些系統。

  • 閥門類型：有閥門的PICC導管和不含閥門的PICC導管。

雖然帶瓣 PICC 導管旨在支援流量控制並減輕某些併發症，但由於醫生的偏好、產品可用性和成本考慮，無瓣 PICC 導管仍然被廣泛使用。

每個細分市場都按市場規模、市場佔有率、治療數量、市場預測、市場成長率、銷售量和平均售價進行分析。

競爭分析

憑藉其豐富的產品系列和先進的定位技術，貝克頓迪金森公司在全球PICC市場佔主導地位。該公司透過捆綁銷售血管通路產品並積極投資教育和培訓，不斷加強與介入性放射科醫生和護理人員的合作。

BD的產品系列包括POWERPICC®、POWERPICC® Solo®、Poly RADPICC®、Per-Q-Cath®、Poly Per-Q-Cath®以及新型POWERPICC® Provena。 POWERPICC® Provena以其較小的直徑為賣點，而Solo®取代了傳統的矽膠PICC導管。

BD公司也銷售大部分三腔PICC導管，並從其導管尖端引導PICC套件中獲得可觀的收入，這些套件與其Sherlock導管尖端放置系統配合使用。該公司認為，越來越多的護理師進行PICC置管以及新興市場對PICC的接受度不斷提高是關鍵的成長要素。

Teleflex收購了Arrow International的產品線後，在PICC市場佔了第二大市場佔有率。雖然其高壓注射相容型PICC和3腔導管表現良好，但尚未達到BD產品系列的水平。

泰利福公司的「ARROW®」PICC導管（採用Chlorag®ard®技術）是一款領先的抗菌和抗血栓產品。該公司在中心靜脈導管市場的強勢地位也可能為其拓展其他血管通路領域提供支援。

Vygon在PICC市場，尤其是在歐洲，已確立了穩固的地位。其PICC產品注重對導管材料的嚴格把控、可靠的置入性能以及與標準化血管通路技術的兼容性。公司透過醫院的穩定採用而非快速的產品線擴張來維持市場佔有率。

技術和實踐趨勢

高壓注射相容型PICC

可注射式PICC導管的重要性日益凸顯，因為它們能夠支援造影造影成像工作流程。這些裝置提供了更大的臨床柔軟性，並減少了對額外血管通路的需求。

這些產品的高平均售價 (ASP) 支撐了其市場價值的成長。

抗菌/抗血栓材料

採用先進材料的PICC導管旨在減少感染疾病和血栓等併發症。這些特性有助於產品差異化，並能提高臨床應用中的可靠性。

預計這些技術在未來仍將十分重要，因為減少併發症仍然是首要目標。

導管尖端定位系統

在PICC置管流程中，導管尖端定位系統及相關工具包的重要性日益凸顯。這些系統有助於精確定位導管尖端，並減少置管過程中的不確定性。

BD 的 Sherlock 晶片放置系統就是這一趨勢的一個例子。

多腔PICC

三腔和雙腔PICC導管可滿足更複雜的治療需求。這些裝置允許透過單根導管進行多種治療和輸液。

多腔產品的採用有助於提高平均售價 (ASP)，並擴大 PICC 在病情更複雜的患者中的應用範圍。

護理師主導的實習

護理師主導的床邊置管仍是PICC導管的一大優勢。這減少了醫生的參與，並提高了工作流程效率。

然而，它的實施取決於能否確保有訓練有素的護理人員和血管通路團隊。

PICC 代替特定 CVC 的情況

在一些先前使用中心靜脈導管（CVC）的慢性血管通路病例中，經皮穿刺置入中心靜脈導管（PICC）的使用正在增加。與CVC相比，PICC感染率較低，這是推動此轉變的主要原因。

然而，在需要高流速的重症監護病例中，中心靜脈導管（CVC）的重要性仍然很高。

地區

本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。

這份報告的意義

  • 目前全球PICC市場規模有多大？預計到2032年將成長多少？
  • 銷售量、治療量、平均售價（ASP）和市場價值如何隨時間變化？
  • 單腔、雙腔和三腔PICC裝置取得了什麼樣的成績？
  • 高壓注射相容型PICC導管在擴大市場規模方面發揮著怎樣的作用？
  • 抗菌和抗血栓材料如何影響產品差異化？
  • PICC 如何取代特定的 CVC 和 PIVC 使用場景？
  • 為什麼護理師主導的床邊置管對於PICC導管的廣泛應用至關重要？
  • 對感染的擔憂和護理人員短缺如何限制市場成長？
  • 全球PICC市場的主要參與者有哪些公司？
  • BD、Teleflex 和 Vygon 在高壓注射、多葉、先進材料和尖端植入式 PICC 導管類別中分別處於什麼位置？

iData Research 的「全球週邊置入中心靜脈導管(PICC) 市場報告」透過設備層面的分析、基於手術的建模、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。本報告可用於評估需求、對標競爭對手、了解 PICC 技術的應用情況，並協助您制定全球 PICC 市場的產業計畫。

目錄

調查方法

  • 步驟 1：專案啟動與團隊組建
  • 步驟 2：準備資料系統並進行二次調查。
  • 步驟 3：設計和準備訪談和調查問卷。
  • 步驟 4：進行初步調查
  • 步驟 5：調查與分析：建立基準估計值
  • 步驟 6：市場預測與分析
  • 步驟 7：辨識策略機遇
  • 步驟 8：最終審核和市場推廣
  • 步驟 9：客戶回饋與市場監測

全球關稅的影響

週邊置入中心靜脈導管市場

  • 摘要整理
    • 全球週邊置入中心靜脈導管市場概覽
    • 競爭分析
    • 目標程式
    • 目標市場
    • 目標區域
  • 介紹
  • 手術次數
    • 中央靜脈導管置入術周邊置入術的完整流程
  • 市場概覽
    • 流明計數
    • 依設備類型
    • 按套件類型
    • 按地區
  • 市場分析與預測
    • 週邊置入中心靜脈導管市場規模
    • 按管腔尺寸分類的周邊週邊置入中心靜脈導管市場
    • 週邊置入中心靜脈導管市場（依器械類型分類）
    • 週邊置入中心靜脈導管市場（按套件類型分類）
  • 促進因素和抑制因素
  • 競爭性市佔率分析
Product Code: iDATA_GLVA26_PICC_MC

Global Peripherally Inserted Central Catheter Market Report to 2032

The global peripherally inserted central catheter market was valued at approximately $838 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 3.3%, reaching $1.1 billion by 2032.

This report covers the global market for peripherally inserted central catheters (PICCs), including single-lumen, double-lumen, and triple-lumen devices.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by new PICC technologies, expanded use of PICCs in place of CVCs and PIVCs, and continued adoption of power-injectable, valved, antimicrobial, and antithrombogenic devices. However, infection concerns and shortages of trained nursing personnel continue to limit stronger adoption.

Market Overview

The global PICC market includes peripherally inserted central catheters used to provide medium- to long-term vascular access through a peripheral vein, with the catheter tip positioned centrally.

PICCs are used across hospital, outpatient, oncology, infusion, and chronic care settings. They are commonly selected when patients require IV access for a week or longer, or when central access is needed without placing a traditional CVC.

The market is segmented by lumen type, device type, kit type, and valve type. This includes single-, double-, and triple-lumen devices, power-injectable and non-power-injectable PICCs, tip-placement and conventional kits, and valved and non-valved PICCs.

Product differentiation and incremental innovation continue to shape competition. Manufacturers have expanded portfolios to include valved, power-injectable, multi-lumen, antimicrobial, and antithrombogenic configurations. These designs are intended to improve clinical performance, reduce complications, broaden use cases, and support modern vascular access protocols.

Market Drivers

New Technologies

New technologies are a major driver in the PICC market. Manufacturers are using product differentiation to support premium pricing and defend ASPs in a competitive vascular access category.

The market has already seen the development of valved PICCs, power-injectable PICCs, triple-lumen PICCs, antimicrobial PICCs, and antithrombogenic PICCs. These products help address clinical needs such as infection prevention, thrombus reduction, imaging compatibility, and multi-therapy access.

New technologies typically command higher selling prices than standard PICCs. This helps prevent overall ASP decline and supports market value growth, even when unit volume gains are moderate.

Ongoing improvements to existing PICC designs are also expected to support adoption. Better designs can reduce infection and complication rates, improve ease of insertion, and increase patient comfort.

Expansion of PICC Use

The expansion of PICC use is another important driver. PICC volume growth depends on the use of PICCs in situations where a CVC or PIVC may previously have been placed.

During hospitalization, most patients receive some kind of IV catheter. Compared with CVCs and PIVCs, the volume of PICCs placed remains lower, leaving room for penetration into adjacent vascular access categories.

PICCs are increasingly being placed at the start of treatment for patients who may require IV access for a week or longer. Although PICCs are more expensive than PIVCs, they do not need to be replaced every 72 hours, which can save time and reduce total care burden.

PICCs are also replacing CVCs in some chronic vascular access cases because they are associated with lower infection rates. With triple-lumen PICCs and antimicrobial technology becoming more common, PICCs are expected to continue capturing selected cases from the CVC market.

Nurse-Led Placement and Workflow Efficiency

One of the practical advantages of PICCs is that they can often be placed by trained nurses at the bedside. This reduces the need for physician placement and can lower procedural costs.

Bedside placement also supports workflow efficiency. It can reduce delays, avoid operating room or interventional suite time in selected cases, and allow hospitals to manage vascular access needs more flexibly.

As more hospitals build vascular access teams and nurse-led placement programs, PICC adoption can increase. This is especially relevant in settings where reducing physician workload, improving access timing, and lowering procedural cost are priorities.

Market Limiters

Infection Rate

Infection risk remains an important limiter for PICCs. A key concern for all catheter types is catheter-related infection, which can create major clinical and financial consequences for hospitals.

A catheter-related infection can cost hospitals an average of $25,000 or more. While PICCs generally have lower infection rates than CVCs, there is ongoing debate about how often PICCs should be used when less risky PIVCs could be used instead.

This concern can limit PICC use in patients who only require short-term access or who can be treated with a simpler peripheral device. The rise of antimicrobial and antithrombogenic PICCs may reduce the effect of this limiter, but infection risk will remain an important factor in device selection.

Shortage of Nursing Personnel

A shortage of nursing personnel can limit PICC placement. One advantage of PICCs is that trained nurses can place them at bedside, but this advantage depends on having enough trained professionals available.

When fewer nurses are available, there may be fewer staff members able to place PICCs efficiently. In those cases, another vascular access device, such as a PIVC, may be inserted instead because it is easier and quicker to place.

This limiter is especially relevant in facilities facing staffing pressure or limited vascular access team capacity. Without enough trained personnel, PICC adoption may be slower than clinical demand would suggest.

Competition from PIVCs and CVCs

PICCs compete with both PIVCs and CVCs. While PICCs can replace some use cases, PIVCs and CVCs remain well suited for specific applications.

PIVCs are easier, faster, and less expensive to place, making them appropriate for many short-term access needs. CVCs remain necessary in critical care cases requiring higher flow rates or more urgent central access.

Because each catheter type has a defined role, PICCs cannot fully replace either category. This limits the total addressable market and keeps PICC growth dependent on appropriate patient selection.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
  • Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
  • Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
  • Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
  • Device scope: The report covers peripherally inserted central catheters segmented by lumen type, device type, kit type, and valve type, including advanced material devices with antimicrobial or antithrombogenic properties.

Markets Covered and Segmentation

Peripherally Inserted Central Catheter Market

  • Lumen type: Single, double, and triple.

Single-lumen PICCs are used when one access channel is sufficient. Double-lumen and triple-lumen PICCs support more complex therapy requirements where multiple medications, infusions, or access needs must be managed.

  • Device type: Power-injectable and non-power-injectable.

Power-injectable PICCs are designed to withstand higher pressure during contrast-enhanced imaging workflows. Non-power-injectable PICCs remain relevant for standard infusion and vascular access needs.

Power-injectable PICCs are further segmented by material type into advanced material devices and conventional devices. Advanced material devices may include antimicrobial or antithrombogenic properties, while conventional devices do not include these enhancements.

  • Kit type: Tip-placement kit and conventional kit.

Tip-placement kits include disposables used with a tip-placement system. Conventional kits include standard placement components without these systems.

  • Valve type: Valved PICC and non-valved PICC.

Valved PICCs are designed to support flow control and reduce certain complications, while non-valved PICCs remain widely used depending on physician preference, product availability, and cost considerations.

Each segment is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

Competitive Analysis

Becton Dickinson holds a dominant position in the global PICC market, supported by its extensive portfolio and tip-confirmation technology. The company bundles vascular access products and actively invests in education and training, reinforcing its position with both interventional radiologists and nurses.

BD's portfolio includes POWERPICC(R), POWERPICC(R) Solo(R), Poly RADPICC(R), Per-Q-Cath(R), Poly Per-Q-Cath(R), and the newer POWERPICC(R) Provena. POWERPICC(R) Provena is marketed as having a smaller diameter, while Solo(R) has replaced older silicone PICC lines.

BD also sells the majority of triple-lumen PICCs and generates significant revenue from tip-guidance PICC kits used with its Sherlock tip-placement systems. The company views the growing number of nurse-placed PICCs and emerging market adoption as key growth drivers.

Teleflex is the second-largest player in the PICC market, having inherited Arrow International's product line. Its power-injectable PICCs and triple-lumen variants have performed strongly, although not at the same level as BD's portfolio.

Teleflex's ARROW(R) PICCs with Chlorag+ard(R) Technology are prominent antimicrobial and antithrombotic devices. The company's strong position in the CVC market may also support its expansion across other vascular access segments.

Vygon holds a stable position in the PICC market, particularly in Europe. Its PICC products emphasize controlled catheter materials, reliable insertion performance, and alignment with standardized vascular access practices. The company maintains share through consistent hospital adoption rather than rapid portfolio expansion.

Technology and Practice Trends

Power-Injectable PICCs

Power-injectable PICCs are increasingly important because they support contrast-enhanced imaging workflows. These devices provide greater clinical flexibility and can reduce the need for additional vascular access placement.

Their higher ASPs support market value growth.

Antimicrobial and Antithrombogenic Materials

Advanced material PICCs are designed to reduce infection and thrombus-related complications. These features support differentiation and may improve clinical confidence.

As complication reduction remains a major focus, these technologies are expected to remain important.

Tip-Placement Systems

Tip-placement systems and related kits are becoming more important in PICC placement workflows. These systems help support accurate catheter tip positioning and reduce uncertainty during insertion.

BD's Sherlock tip-placement systems are an example of this trend.

Multi-Lumen PICCs

Triple-lumen and double-lumen PICCs support more complex treatment needs. These devices allow multiple therapies or infusions to be managed through one catheter.

Multi-lumen adoption supports higher ASPs and broadens PICC use in more complex patients.

Nurse-Led Placement

Nurse-led bedside placement remains a major advantage for PICCs. It can reduce physician involvement and improve workflow efficiency.

However, adoption depends on the availability of trained nursing personnel and vascular access teams.

PICCs Replacing Selected CVC Use

PICCs are increasingly used in some chronic access cases where CVCs were previously placed. Their lower infection rate compared with CVCs supports this shift.

However, CVCs remain important in critical care cases requiring high flow rates.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

  • How large is the global PICC market today, and how much is it expected to grow through 2032?
  • How are unit sales, procedure numbers, ASPs, and market values changing over time?
  • How are single-lumen, double-lumen, and triple-lumen PICCs performing?
  • What role do power-injectable PICCs play in market value growth?
  • How are antimicrobial and antithrombogenic materials affecting product differentiation?
  • How are PICCs replacing selected CVC and PIVC use cases?
  • Why is nurse-led bedside placement important to PICC adoption?
  • How do infection concerns and nursing shortages limit market growth?
  • Which companies lead the global PICC market?
  • How are BD, Teleflex, and Vygon positioned across power-injectable, multi-lumen, advanced material, and tip-placement PICC categories?

The Global Peripherally Inserted Central Catheter Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand PICC technology adoption, and support commercial planning in the global PICC market.

TABLE OF CONTENT

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Peripherally Inserted Central Catheter Market

  • 7.1 Executive Summary
    • 7.1.1 Global Peripherally Inserted Central Catheter Market Overview
    • 7.1.2 Competitive Analysis
    • 7.1.3 Procedures Included
    • 7.1.4 Markets Included
    • 7.1.5 Regions Included
  • 7.2 Introduction
  • 7.3 Procedure Numbers
    • 7.3.1 Total Peripherally Inserted Central Catheter Procedures
      • 7.3.1.1 Power-Injectable Picc Procedures
      • 7.3.1.2 Non-Power-Injectable Picc Procedures
  • 7.4 Market Overview
    • 7.4.1 By Lumen Count
    • 7.4.2 By Device Type
    • 7.4.3 By Kit Type
    • 7.4.4 By Region
  • 7.5 Market Analysis And Forecast
    • 7.5.1 Total Peripherally Inserted Central Catheter Market
    • 7.5.2 Peripherally Inserted Central Catheter Market By Lumen Count
      • 7.5.2.1 Single-Lumen Peripherally Inserted Central Catheter Market
      • 7.5.2.2 Double-Lumen Peripherally Inserted Central Catheter Market
      • 7.5.2.3 Triple-Lumen Peripherally Inserted Central Catheter Market
    • 7.5.3 Peripherally Inserted Central Catheter Market By Device Type
      • 7.5.3.1 Power-Injectable Peripherally Inserted Central Catheter Market
      • 7.5.3.1.1 Advanced Material Power-Injectable Peripherally Inserted Central Catheter Kit Market
      • 7.5.3.1.2 Conventional Power-Injectable Peripherally Inserted Central Catheter Kit Market
      • 7.5.3.2 Non-Power-Injectable Peripherally Inserted Central Catheter Market
    • 7.5.4 Peripherally Inserted Central Catheter Market By Kit Type
      • 7.5.4.1 Tip-Placement Kit Peripherally Inserted Central Catheter Market
      • 7.5.4.2 Conventional Kit Peripherally Inserted Central Catheter Market
  • 7.6 Drivers And Limiters
    • 7.6.1 Market Drivers
    • 7.6.2 Market Limiters
  • 7.7 Competitive Market Share Analysis

LIST OF CHARTS

  • Chart 7-1: Peripherally Inserted Central Catheter Market, Global, 2025 & 2032
  • Chart 7-2: Peripherally Inserted Central Catheter Procedures, Global, 2025
  • Chart 7-3: Peripherally Inserted Central Catheter Procedures by Region, Global, 2022 - 2032
  • Chart 7-4: Peripherally Inserted Central Catheter Market by Lumen Count, Global, 2022 - 2032
  • Chart 7-5: Peripherally Inserted Central Catheter Market by Device Type, Global, 2022 - 2032
  • Chart 7-6: Peripherally Inserted Central Catheter Market by Kit Type, Global, 2022 - 2032
  • Chart 7-7: Peripherally Inserted Central Catheter Market by Region, Global, 2022 - 2032
  • Chart 7-8: Leading Competitors, Peripherally Inserted Central Catheter Market, Global, 2025

LIST OF FIGURES

  • Figure 7-1: Peripherally Inserted Central Catheter Procedures Covered
  • Figure 7-2: Peripherally Inserted Central Catheter Markets Covered
  • Figure 7-3: Peripherally Inserted Central Catheter Regions Covered, Global (1 of 2)
  • Figure 7-4: Peripherally Inserted Central Catheter Regions Covered, Global (2 of 2)
  • Figure 7-5: Peripherally Inserted Central Catheter Procedures by Region, Global, 2022 - 2032
  • Figure 7-6: Peripherally Inserted Central Catheter Procedures by Country, North America, 2022 - 2032
  • Figure 7-7: Peripherally Inserted Central Catheter Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 7-8: Peripherally Inserted Central Catheter Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 7-9: Peripherally Inserted Central Catheter Procedures by Country, Western Europe, 2022 - 2032
  • Figure 7-10: Peripherally Inserted Central Catheter Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 7-11: Peripherally Inserted Central Catheter Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 7-12: Peripherally Inserted Central Catheter Procedures by Country, Middle East, 2022 - 2032
  • Figure 7-13: Peripherally Inserted Central Catheter Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 7-14: Peripherally Inserted Central Catheter Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 7-15: Peripherally Inserted Central Catheter Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 7-16: Peripherally Inserted Central Catheter Procedures by Country, Africa, 2022 - 2032
  • Figure 7-17: Power-Injectable PICC Procedures by Region, Global, 2022 - 2032
  • Figure 7-18: Power-Injectable PICC Procedures by Country, North America, 2022 - 2032
  • Figure 7-19: Power-Injectable PICC Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 7-20: Power-Injectable PICC Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 7-21: Power-Injectable PICC Procedures by Country, Western Europe, 2022 - 2032
  • Figure 7-22: Power-Injectable PICC Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 7-23: Power-Injectable PICC Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 7-24: Power-Injectable PICC Procedures by Country, Middle East, 2022 - 2032
  • Figure 7-25: Power-Injectable PICC Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 7-26: Power-Injectable PICC Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 7-27: Power-Injectable PICC Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 7-28: Power-Injectable PICC Procedures by Country, Africa, 2022 - 2032
  • Figure 7-29: Non-Power-Injectable PICC Procedures by Region, Global, 2022 - 2032
  • Figure 7-30: Non-Power-Injectable PICC Procedures by Country, North America, 2022 - 2032
  • Figure 7-31: Non-Power-Injectable PICC Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 7-32: Non-Power-Injectable PICC Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 7-33: Non-Power-Injectable PICC Procedures by Country, Western Europe, 2022 - 2032
  • Figure 7-34: Non-Power-Injectable PICC Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 7-35: Non-Power-Injectable PICC Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 7-36: Non-Power-Injectable PICC Procedures by Country, Middle East, 2022 - 2032
  • Figure 7-37: Non-Power-Injectable PICC Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 7-38: Non-Power-Injectable PICC Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 7-39: Non-Power-Injectable PICC Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 7-40: Non-Power-Injectable PICC Procedures by Country, Africa, 2022 - 2032
  • Figure 7-41: Peripherally Inserted Central Catheter Market by Lumen Count, Global, 2022 - 2032 (US$M)
  • Figure 7-42: Peripherally Inserted Central Catheter Market by Device Type, Global, 2022 - 2032 (US$M)
  • Figure 7-43: Peripherally Inserted Central Catheter Market by Kit Type, Global, 2022 - 2032 (US$M)
  • Figure 7-44: Peripherally Inserted Central Catheter Market by Region, Global, 2022 - 2032 (US$M)
  • Figure 7-45: Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-46: Units Sold by Region, Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-47: Average Selling Price by Region, Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 7-48: Market Value by Region, Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 7-49: Single-Lumen Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-50: Units Sold by Region, Single-Lumen Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-51: Average Selling Price by Region, Single-Lumen Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 7-52: Market Value by Region, Single-Lumen Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 7-53: Double-Lumen Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-54: Units Sold by Region, Double-Lumen Peripherally Inserted Central Catheter Market, Global, 2022- 2032
  • Figure 7-55: Average Selling Price by Region, Double-Lumen Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 7-56: Market Value by Region, Double-Lumen Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 7-57: Triple-Lumen Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-58: Units Sold by Region, Triple-Lumen Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-59: Average Selling Price by Region, Triple-Lumen Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 7-60: Market Value by Region, Triple-Lumen Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 7-61: Power-Injectable Peripherally Inserted Central Catheter Market by Type, U.S., 2022 - 2032 (US$M)
  • Figure 7-62: Power-Injectable Peripherally Inserted Central Catheter Market, U.S., 2022 - 2032
  • Figure 7-63: Units Sold by Region, Power-Injectable Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-64: Average Selling Price by Region, Power-Injectable Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 7-65: Market Value by Region, Power-Injectable Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 7-66: Advanced Material Power-Injectable Peripherally Inserted Central Catheter Market, U.S., 2022 - 2032
  • Figure 7-67: Units Sold by Region, Advanced Material Power-Injectable Peripherally Inserted Central Catheter, Global, 2022 - 2032
  • Figure 7-68: Average Selling Price by Region, Advanced Material Power-Injectable Peripherally Inserted Central Catheter, Global, 2022 - 2032 (US$)
  • Figure 7-69: Market Value by Region, Advanced Material Power-Injectable Peripherally Inserted Central Catheter, Global, 2022 - 2032 (US$M)
  • Figure 7-70: Conventional Power-Injectable Peripherally Inserted Central Catheter Market, U.S., 2022 - 2032
  • Figure 7-71: Units Sold by Region, Conventional Material Power-Injectable Peripherally Inserted Central Catheter, Global, 2022 - 2032
  • Figure 7-72: Average Selling Price by Region, Conventional Material Power-Injectable Peripherally Inserted Central Catheter, Global, 2022 - 2032 (US$)
  • Figure 7-73: Market Value by Region, Conventional Material Power-Injectable Peripherally Inserted Central Catheter, Global, 2022 - 2032 (US$M)
  • Figure 7-74: Non-Power-Injectable Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-75: Units Sold by Region, Non-Power-Injectable Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-76: Average Selling Price by Region, Non-Power-Injectable Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 7-77: Market Value by Region, Non-Power-Injectable Peripherally Inserted Central Catheter Market, Global, 2022- 2032 (US$M)
  • Figure 7-78: Tip-Placement Kit Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-79: Units Sold by Region, Tip-Placement Kit Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-80: Average Selling Price by Region, Tip-Placement Kit Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 7-81: Market Value by Region, Tip-Placement Kit Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 7-82: Conventional Kit Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-83: Units Sold by Region, Conventional Kit Peripherally Inserted Central Catheter Market, Global, 2022 - 2032
  • Figure 7-84: Average Selling Price by Region, Conventional Kit Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 7-85: Market Value by Region, Conventional Kit Peripherally Inserted Central Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 7-86: Leading Competitors, Peripherally Inserted Central Catheter Market, Global, 2025